| abstract |
The present invention relates to chimeric peptides, the primary structure of which protects at least one segment that inhibits the activation of the virus's NS3 protease from the Flaviviridae family, they also contain cell penetrating segments and they Can inhibit or dilute infection. The present invention also relates to pharmaceutical compositions containing these chimeric peptides for the prophylaxis and / or treatment against infection caused by a virus from the Flaviviridae family. |